SCHEMBL10113436

SCHEMBL10113436

CC(C(=O)O)c1ccc(N2Cc3c(cccc3-c3cccnc3)C2=O)cc1

nearest known ligand 0.58

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
TP53 P04637 2/20 0.58
SMN1; SMN2 Q16637 2/20 0.58
MEN1 O00255 1/20 0.58
LMNA P02545 1/20 0.58
CYP2D6 P10635 1/20 0.58
CYP2C19 P33261 1/20 0.58
KMT2A Q03164 1/20 0.58
NPC1 O15118 1/20 0.58
PGR P06401 1/20 0.58
CYP3A4 P08684 1/20 0.58
GAA P10253 1/20 0.58
PKM P14618 1/20 0.58
NFKB1 P19838 1/20 0.58
DRD1 P21728 1/20 0.58
HTT P42858 1/20 0.58
RAB9A P51151 1/20 0.58
NFKB2 Q00653 1/20 0.58
RELA Q04206 1/20 0.58
HDAC6 Q9UBN7 1/20 0.58
DHPS P49366 2/20 0.50

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL10113499 0.90 TP53 (0.60) TP53SMN1; SMN2MEN1LMNACYP2D6
SCHEMBL10085866 0.89 MEN1 (0.70) TP53SMN1; SMN2MEN1LMNACYP2D6
SCHEMBL10085756 0.86 TP53 (0.64) TP53SMN1; SMN2MEN1LMNACYP2D6
SCHEMBL10085794 0.85 TP53 (0.61) TP53SMN1; SMN2MEN1LMNACYP2D6
SCHEMBL10086394 0.84 TP53 (0.63) TP53SMN1; SMN2MEN1LMNACYP2D6
SCHEMBL10085860 0.83 TP53 (0.61) TP53SMN1; SMN2MEN1LMNACYP2D6
SCHEMBL10085767 0.82 TP53 (0.61) TP53SMN1; SMN2MEN1LMNACYP2D6
SCHEMBL10086397 0.81 TP53 (0.58) TP53SMN1; SMN2MEN1LMNACYP2D6
SCHEMBL10085479 0.81 TP53 (0.58) TP53SMN1; SMN2MEN1LMNACYP2D6
SCHEMBL10085485 0.81 NPC1 (0.67) TP53SMN1; SMN2MEN1LMNACYP2D6

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8110681-B2 Compounds for the treatment of spinal muscular atrophy and other uses THE UNITED STATES OF AMERICA AS REPRESENTED BY THE SECRETARY, DEPARTMENT OF HEALTH AND HUMAN SERVICES (US) 2012-02-07 US disclosed
US-8110681-B2 Compounds for the treatment of spinal muscular atrophy and other uses THE UNITED STATES OF AMERICA AS REPRESENTED BY THE SECRETARY, DEPARTMENT OF HEALTH AND HUMAN SERVICES (US) 2012-02-07 US disclosed